Palvella Therapeutics, Inc. PVLA

Updated: 18 Jun 2026

NASDAQ | Biotech | Biotech / Rare skin diseases

No signal published yet

We already track Palvella Therapeutics and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Palvella Therapeutics free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Biotech / Rare skin diseases
We're already tracking Palvella Therapeutics, Inc. — here are the latest events we've registered

Recent News

  • On June 16, 2026, the company announced that stockholders approved board elections and an amendment to its equity incentive plan at the annual meeting. Following positive Phase 3 results, the company remains on track to submit a New Drug Application for its lead candidate in the second half of 2026.

What Firelda Watch includes for Palvella Therapeutics, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Palvella Therapeutics, Inc. will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Black Mammoth Metals Corp
BMM
NEUTRAL
Hansa Biopharma AB (publ)
HNSA
HOLD
Crustal Resources B
HOLD
Crustal Minerals
CRUST B
NEUTRAL
Bioarctic
BIOA B
BUY

Biotech

More companies in this sector

Want to follow Palvella Therapeutics, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Palvella Therapeutics free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Palvella Therapeutics, Inc. PVLA
Palvella Therapeutics — follow and we'll monitor it
Follow Palvella Therapeutics free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.